116515 ⎘
Hydrolases acting on glycosyl compounds, i.e. glycosylases (3.2); Glycosidases, i.e. enzymes hydrolysing O- and S-glycosyl compounds (3.2.1) Lysozyme (3.2.1.17)
Combination treatment for atopic dermatitis
#302BACTERIAL LYSINS AND USES THEREOF
#3033-aryl propiolonitrile compounds for thiol labeling
#304Use of hydrolytic and oxidative enzymes to dissolve biofilm in airway passages
#305APPARATUS AND METHOD FOR DEHYDRATING BIOLOGICAL MATERIALS
#306Methods of generating and screening for lytic chimeric polypeptides
#307THERMOLABILE DRUG RELEASE FORMULATION
#308Internalization of proteins into hollowed gold nanostructures
#309Viscosity-reducing excipient compounds for protein formulations
#310BORONATE-MEDIATED DELIVERY OF MOLECULES INTO CELLS
#311VISCOSITY-REDUCING EXCIPIENT COMPOUNDS FOR PROTEIN FORMULATIONS
#312EGG PROTEIN FORMULATIONS AND METHODS OF MANUFACTURE THEREOF
#313Egg protein formulations and methods of manufacture thereof
#314Endolysins active against bacteria, pharmaceutical compositions, and methods relating thereto
#315ANTIMICROBIAL MURAMIDASE
#316Albumin conjugated temperature and pH-sensitive multi-block copolymer, a method of preparation thereof and drug delivery system using the same
#317Polypeptides having endolysin activity and uses thereof
#318Methods to protect against and treat multiple sclerosis
#319ENDOLYSIN OBPGPLYS
#320Technology for the Preparation of Microparticles
#321Use of tryptophan rich protein hydrolysates
#322Bacteriophage lysin and antibiotic combinations against gram positive bacteria
#323Method for preparing high quality crystals by directing ionized gas molecules through and/or over a saturated solution comprising a protein
#324Method for producing a polyglycerol nanogel for the encapsulation and release of biologically active substances
#325bacteriophage lysins for detection and treatment of gram positive bacteria
#326Enhanced staphylolytic activity of the bacteriophage vBSauS-philPLA88 virion-associated peptidoglycan hydrolase HydH5: fusions, deletions and synergy with LysH5
#327Composition capable of improving stability of bacteriophage lysin proteins
#328Activated Polyoxazolines and Conjugates and Compositions Comprising the Same
#329Collagen mixture and method of making the same
#330Efficient aqueous encapsulation and controlled release of bioactive agents
#331Conjugates of biologically active molecules to functionalized polymers
#332Antimicrobial agents
#333Cucurbituril-based hydrogels
#334ANTIVIRAL COMPOSITIONS AND METHODS OF THEIR USE
#335Process to produce a tryptophan-enriched lysozyme hydrolysate
#336Endolysin OBPgpLYS
#337Immunogenic compositions and reagents for preparing
#338Lysozymes
#339Injectable, Non-Aqueous Suspension with High Concentration of Therapeutic Agent
#340Methods and compositions for treating mucosal tissue disorders
#341Combination of growth factors, cytokines, antibacterial/antiviral factors, stem cell stimulating factors, complement proteins C3A/C4A, and chemotactic factors
#342Polypeptides having lysozyme activity and polynucleotides encoding same
#343Stabilization of biomolecules using sugar polymers
#344Polypeptides having lysozyme activity and polynucleotides encoding same
#345GPCR comprising an IC2 insertion
#346TOPICALLY OR ORALLY APPLIED ALOE, DISTILLED WATER, SODIUM CHLORIDE, AND LYSOZYME MIXTURE AND METHOD OF PRODUCING THE MIXTURE
#347Immunogenic compositions in particulate form and methods for producing the same
#348prophage φSH2 endolysin is lytic for
#349Bacteriophage lysin and antibiotic combinations against gram positive bacteria
#350Enhanced antimicrobial lytic activity of a chimeric Ply187 endolysin
#351Methods and delivery vehicles for providing throat relief
#352Enhanced staphylolytic activity of the bacteriophage vBSauS-philPLA88 virion-associated peptidoglycan hydrolase HydH5: fusions, deletions and synergy with LysH5
#353Therapeutic charge engineered variants of lysozyme and methods for using same to treat infections
#354Method of reducing biofilms
#355ANTIVIRAL COMPOSITIONS AND METHODS OF THEIR USE
#356Method of performing PCR reaction in continuously flowing microfluidic plugs
#357Artificial saliva comprising hyaluronic acid
#358Variants of a lysozyme and polynucleotides encoding same
#359ARTIFICIAL PEPTIDOGLYCAN LYSING ENZYMES AND PEPTIDOGLYCAN BINDING PROTEINS
#360INACTIVATION OF OFF-TASTE INDUCING ENZYMES
#361GPCR comprising an IC2 insertion
#362Endolysin OBPgpLYS
#363Antimicrobial agents
#364Bioerodible silicon-based devices for delivery of therapeutic agents
#365Technology for the Preparation of Microparticles
#366Novel Polypeptides Having Endolysin Activity And Uses Thereof
#367ENDOLYSIN PLYP40
#368Human Aadenosine receptor crystals and uses thereof
#369Injectable, non-aqueous suspension with high concentration of therapeutic agent
#370APPARATUS AND METHOD FOR DEHYDRATING BIOLOGICAL MATERIALS
#371Lactoferrin and angiogenin compositions and uses thereof
#372Microfabricated nanopore device for sustained release of therapeutic agent
#373Method for conducting an autocatalytic reaction in plugs in a microfluidic system
#374Device for pressure-driven plug transport comprising microchannel with traps
#375Method for conducting reactions involving biological molecules in plugs in a microfluidic system
#376DEVICE AND METHOD FOR PRESSURE-DRIVEN PLUG TRANSPORT
#377Method for obtaining a collection of plugs comprising biological molecules
#378NUCLEIC ACIDS, BACTERIA, AND METHODS FOR DEGRADING THE PEPTIDOGLYCAN LAYER OF A CELL WALL
#379DEVICE AND METHOD FOR PRESSURE-DRIVEN PLUG TRANSPORT
#380Mixture of peptide-bound tryptophan and polypeptide-bound tryptophan
#381USE OF HYDROLYTIC AND OXIDATIVE ENZYMES TO DISSOLVE BIOFILM IN AIRWAY PASSAGES
#382Hemostatic Sponge with Enzyme and Method of Manufacture
#383NOVEL METHODS AND MEDICAMENT FOR TREATING INFECTIOUS DISEASES INVOLVING MICROBIAL BIOFILMS
#384Dry treatment mixture and methods of production and use
#385DEVICE AND METHOD FOR PRESSURE-DRIVEN PLUG TRANSPORT AND REACTION
#386USE OF HYDROLYTIC AND OXIDATIVE ENZYMES TO DISSOLVE BIOFILM IN EARS
#387Use of antimicrobial proteins and peptides for the treatment of otitis media and paranasal sinusitis
#388Method for identifying smoker or ex-smoker at risk of chronic obstructive pulmonary disease
#389Compositions and methods for enzymatic treatment of lung disorders
#390Method Of Complexing A Protein By The Use Of A Dispersed System And Proteins Thereof
#391Chromatography Membranes, Devices Containing Them, and Methods of Use Thereof
#392NOVEL COMPOSITIONS FOR PREVENTION AND TREATMENT OF MASTITIS AND METRITIS
#393Demucilaged flax sprouts and their by-product as well as production and application thereof
#394Technology for the Preparation of Microparticles
#395USE OF ANTIMICROBIAL PROTEINS AND PEPTIDES FOR THE TREATMENT OF OTITIS MEDIA AND PARANASAL SINUSITIS
#396INJECTABLE, NONAQUEOUS SUSPENSION WITH HIGH CONCENTRATION OF THERAPEUTIC AGENT
#397Compositions containing lysozyme and C-1/C-4 polysaccharides and use thereof in oral care, cosmetology and dermatology, contraception, urology and gynecology
#398Coenzyme Q10, lactoferrin and angiogenin compositions and uses thereof
#399USE OF ANTIMICROBIAL PROTEINS AND PEPTIDES FOR THE TREATMENT OF OTITIS MEDIA AND PARANASAL SINUSITIS
#400Novel methods and medicament for treating infectious diseases involving microbial biofilms
#401Microfabricated nanopore device for sustained release of therapeutic agent
#402Bacteriophage lysins for and other bacteria
#403Composition having bacteristatic and bactericidal activity against bacterial spores and vegetative cells and process for treating foods therewith
#404Uses of sysnergistic bacteriophage lytic enzymes for prevention and treatment of bacterial infections
#405Sperm specific lysozyme-like proteins
#406Use of antimicrobial proteins and peptides for the treatment of otitis media and paranasal sinusitis
#407Phage-associated lytic enzymes for treatment of and related conditions
#408Method for performing crystallization and reactions in pressure-driven fluid plugs
#409Method of complexing a protein by the use of a dispersed system and proteins thereof
#410NK-lysin peptide compositions and methods for their use as antimicrobial/antiviral agents